Chimerix Inc

NASDAQ:CMRX  
1.83
-0.07 (-3.68%)
Business Deals

Chimerix Awarded Barda Contract For Tembexa As Medical Countermeasure For Smallpox

Published: 08/29/2022 14:54 GMT
Chimerix Inc (CMRX) - Chimerix Awarded Barda Contract for Tembexa As Medical Countermeasure for Smallpox.
Chimerix Inc - Initial Procurement of 319,000 Treatment Courses for $115m With Additional Procurements at Barda's Discretion Over 10 Years.
Chimerix Inc - Emergent Biosolutions, Inc. Payment Increases to $238m Upfront and $136.5m in Potential Milestones.
Chimerix Inc - 10-year Contract is Valued at Approximately $551 Million in Total If Barda Elects to Exercise All Options.
Chimerix - Contract Supports Post-marketing Activities of About $13 Million, for a Total Potential Contract Value of Up to $680 Million.